Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly

Links shared publicly online about this topic.

  • 245
    total visits

Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly

medicalnewstoday.com —

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase I

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Pharma, Copaxone, Teva Pharmaceutical Industries

  • Share

Most Recently Shared on June 4, 2011 at 4:48 am By:

MS_Wisdom2 OrganizedWisdom MS

Teva Completes Enrollment In Phase III Multiple Sclerosis Trial Evaluating Glatiramer Acetate Three Times Weekly... http://bit.ly/lytAE0

11 months ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

MNT Multiple Scl MNT Multiple Scl

Advertisement